Trial intelligence / Profile preview

Self-administered tDCS in Major Depressive Disorder

NCT04543123Phase 4Completed

Sponsor
Jeong-Ho Chae
Start
Nov 2017
Primary completion
May 2019
Countries
1
01

Overview

Phase 4, randomised, single-blind trial (2 arms), sponsored by Jeong-Ho Chae. Primary endpoint: Hamilton Depression Scale at 6 weeks. Started Nov 2017; status: completed.

Beyond the preview

Go deeper on NCT04543123.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04543123.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call